Section

Suven Pharma stock rises 6% on nod to acquire Sapala Organics for Rs 230 cr

By Business Standard - 5 months ago
The surge came after Suven Pharmaceuticals said that it has entered into a definitive agreement to acquire a controlling stake of Sapala Organic for Rs 229.5 crore, in an all cash deal

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.